CEO departures
213 filings were classified as CEO departure in the last 90 days. The most recent was LKQ Corporation (LKQ) on Oct 23, 2026.
Latest filings
| Filed | Issuer | Event | Classified excerpt | Source |
|---|---|---|---|---|
| LKQLKQ Corporation | CEO departure | “On October 23, 2026, the Board of Directors ... announced that Justin L. Jude ceased to serve as the Company's President and Chief Executive Officer and resigned as a member of the Board, in each case, effective October 23, 2026.” | 8-K ↗ | |
| ARDTArdent Health, Inc. | CEO departure | “Martin J. Bonick's employment as President and Chief Executive Officer of Ardent Health, Inc. and his service as a member of the Company's Board of Directors ended effective June 2, 2026.” | 8-K ↗ | |
| No ticker CIK 0001876255 | CEO departure | “On October 20, 2026, Peter Gordon and Marguerite Brogan notified the Fund of their intention to resign from their roles as Chief Executive Officer and Chief Financial Officer, respectively, of the Fund, effective October 23, 2026.” | 8-K ↗ | |
| HODOHouse of Doge Inc. | CEO departure | “On October 22, 2026, Marco Margiotta resigned as Chief Executive Officer ... of the Company.” | 8-K ↗ | |
| GBFHGBank Financial Holdings Inc. | CEO departure | “On October 22, 2026, Mr. Edward M. Nigro... tendered his resignation to the Boards of Directors of the Company and the Bank as Executive Chairman and Chief Executive Officer of the Company and as Executive Chairman and a director of the Bank. On October 22, 2026, the Boards of Directors... voted to accept Mr. Nigro's resignations, effective immediately. Mr. Nigro will continue to serve as a director of the Company.” | 8-K ↗ | |
| No ticker CIK 0001329842 | CEO departure | “On October 22, 2026, the Federal Home Loan Bank of New York ("FHLBNY") announced that Randolph C. Snook resigned as President and Chief Executive Officer of the FHLBNY effective October 20, 2026 and will serve as a senior advisor to the FHLBNY through December 31, 2026, to assist in the leadership transition.” | 8-K ↗ | |
| UFPIUFP Industries, Inc. | CEO departure | “Matthew J. Missad... will be retiring from his employment with the Company on December 31, 2026... Mr. Missad was appointed Executive Chairman... following his transition from his prior role as Chief Executive Officer (CEO) of the Company. Following his Retirement Date, Mr. Missad will remain as Chairman of the Board.” | 8-K ↗ | |
| OPALOPAL Fuels Inc. | CEO departure | “On October 19, 2026, Jonathan Maurer, Co-Chief Executive Officer of OPAL Fuels Inc. (the "Company"), notified the Company that he intends to retire from his role as Co-Chief Executive Officer effective as of March 31, 2027. Mr. Maurer plans to be available to the Company in a Senior Advisor role for an appropriate period of time following his retirement to support a smooth transition.” | 8-K ↗ | |
| CLFDClearfield, Inc. | CEO departure | “On October 15, 2026, Clearfield, Inc. and Cheryl Beranek, President and Chief Executive Officer of the Company, entered into a transition agreement to facilitate Ms. Beranek's retirement on March 31, 2027 and the smooth transition to a successor President and Chief Executive Officer.” | 8-K ↗ | |
| No ticker CIK 0001497120 | CEO departure | “Effective October 16, 2026, George England resigned from his position as a member of the Board of Directors of the Company and as Chief Executive Officer of Global Vision Holdings, Inc. (the "Company"). Mr. England's decision to resign was not the result of any disagreement with the Company, its management, the Board of Directors, or any matter relating to the Company's operations, policies, or practices.” | 8-K ↗ | |
| No ticker CIK 0001175680 | CEO departure | “Also on October 16, 2026, Dr. Lalezari confirmed his resignation as the Company's Chief Executive Officer effective October 20, 2026, and accepted a non-executive role with the Company as Head of Research and Translational Sciences.” | 8-K ↗ | |
| ZDGEZedge, Inc. | CEO departure | “Jonathan Reich ceased to serve as Chief Executive Officer of the Company effective as of September 30, 2026, and, effective October 1, 2026, Mr. Reich commenced service as President and Chief Operating Officer of the Company.” | 8-K ↗ | |
| CHRDChord Energy Corporation | CEO departure | “On October 16, 2026, Daniel Brown notified the Company of his decision to resign as President & Chief Executive Officer, as a member of the Board of Directors of the Company (the "Board"), and from all other positions he holds with the Company and its subsidiaries, effective October 19, 2026, to pursue another professional opportunity. Because Mr. Brown is resigning from his employment with the Company without Good Reason (as defined in the Company's Executive Severance Plan), he will not be entitled to any severance related payments or benefits.” | 8-K ↗ | |
| HBCPHome Bancorp, Inc. | CEO departure | “After more than 45 years of distinguished service and leadership, Mr. John W. Bordelon will retire as Chief Executive Officer ("CEO") of Home Bancorp, Inc. ... effective January 8, 2027. Following his retirement as CEO, he will continue to serve as Chairman and as a member of the Boards of Directors of the Company and the Bank.” | 8-K ↗ | |
| IRWDIronwood Pharmaceuticals, Inc. | CEO departure | “Thomas McCourt notified the Board of his decision to retire as Chief Executive Officer, effective December 31, 2026, following 17 years of service to the Company, including five years in that role.” | 8-K ↗ | |
| YHCLQR House Inc. | CEO departure | “Effective October 16, 2026, Mr. Sean Dollinger resigned as Chief Executive Officer of the Company and from all other positions held by him as an officer, director, employee, manager, authorized signatory or representative of the Company and its subsidiaries and affiliates.” | 8-K ↗ | |
| FOXFFox Factory Holding Corp. | CEO departure | “On October 15, 2026, the Board of Directors ... approved a leadership transition plan pursuant to which Michael C. Dennison, the Company's Chief Executive Officer ("CEO"), is stepping down from his role as CEO. Mr. Dennison resigned from his role as a member of the Board, effective October 15, 2026.” | 8-K ↗ | |
| LASELaser Photonics Corporation | CEO departure | “On October 16, 2026, the Company announced that Wayne Tupuola, the Chief Executive Officer ... resigned from serving as the CEO ... effective as of October 13, 2026. Mr. Tupuola resigned for personal reasons and his resignation is not the result of any disagreement with the Company.” | 8-K ↗ | |
| MANManpowerGroup | CEO departure | “Mr. Prising's decision on the same day to retire as the Company's Chief Executive Officer, effective as of the Transition Date.” | 8-K ↗ | |
| VSTMVerastem, Inc. | CEO departure | “Daniel W. Paterson notified the Board of Directors ... of his decision to retire as President and Chief Executive Officer of the Company, effective January 1, 2027.” | 8-K ↗ | |
| CCOClear Channel Outdoor Holdings, Inc. | CEO departure | “Effective upon the consummation of the Merger, Scott Wells ceased to serve as Chief Executive Officer and President and separated from the Company and its subsidiaries.” | 8-K ↗ | |
| BLCOBausch + Lomb Corporation | CEO departure | “Brent Saunders, Chief Executive Officer of the Company and a member of the Company's board of directors (the 'Board'), and the Board have mutually agreed that Mr. Saunders will depart from the Company, effective as of October 12, 2026... Mr. Saunders' departure from the Company and the Board is not due to any dispute or disagreement with the Company, its management or the Board.” | 8-K ↗ | |
| HRMYHarmony Biosciences Holdings, Inc. | CEO departure | “On October 12, 2026, Harmony Biosciences Holdings, Inc. announced that Jeffrey M. Dayno, M.D., as part of a leadership succession plan, will be retiring as the Company's President and Chief Executive Officer ... effective as of December 31, 2026, at 11:59 p.m. Eastern Time, and will serve as a non-executive advisor to the Company through 2027.” | 8-K ↗ | |
| XTIAXTI Aerospace, Inc. | CEO departure | “The internal review concerned matters relating to the Company's former Chief Executive Officer, who resigned on August 17, 2026.” | 8-K ↗ | |
| QNCXQuince Therapeutics, Inc. | CEO departure | “Effective as of October 8, 2026, Dirk Thye, M.D., resigned as Chief Executive Officer and Chief Medical Officer, as well as a director, of Quince Therapeutics, Inc.” | 8-K ↗ |
GET /stocks/filings/8-K/vX/disclosures?tertiary_category=ceo_departure&filing_date.gte=2026-07-28&sort=filing_date.desc&limit=1000Each category is a separate request; rows are merged and de-duplicated by filing.
{
"status": "OK",
"results": [
{
"tickers": [
"LKQ"
],
"cik": "0001065696",
"accession_number": "0001065696-26-000047",
"filing_date": "2026-10-23",
"primary_category": "leadership_and_governance",
"secondary_category": "executive_leadership",
"tertiary_category": "ceo_departure",
"supporting_text": "On October 23, 2026, the Board of Directors ... announced that Justin L. Jude ceased to serve as the Company's President and Chief Executive Officer and resigned as a member of the Board, in each case, effective October 23, 2026.",
"filing_url": "https://www.sec.gov/Archives/edgar/data/1065696/0001065696-26-000047.txt"
},
{
"tickers": [
"HODO"
],
"cik": "0001903595",
"accession_number": "0001213900-26-112135",
"filing_date": "2026-10-23",
"primary_category": "leadership_and_governance",
"secondary_category": "executive_leadership",
"tertiary_category": "ceo_departure",
"supporting_text": "On October 22, 2026, Marco Margiotta resigned as Chief Executive Officer ... of the Company.",
"filing_url": "https://www.sec.gov/Archives/edgar/data/1903595/0001213900-26-112135.txt"
}
]
}
// trimmed to 2 resultsShowing the 25 most recent of 213Query this data with the API
What these filings mean
- CEO departure
- CEO departure, resignation, retirement, termination, or death with circumstances and transition.
Usually filed under 8-K Item 5.02.
How this page works
- Every 8-K disclosure from the last 90 days is classified, and those in the categories above are listed here.
- One row per filing: a filing in several categories appears once.
- Labels are assigned automatically from the filing text, so always check the linked 8-K.
Other 8-K events
- Listing deficiency & delisting notices
- CFO & executive departures
- Stock splits
- Merger agreements & completions
- Share buyback programs
- Dividend declarations
- Earnings releases
- Guidance updates
- Clinical trial results
- Regulatory decisions
- Bankruptcy filings
- Financial restatements
- Auditor changes
- Cybersecurity incidents
- Layoffs & restructuring
Frequently asked questions
What is an SEC Form 8-K?
An 8-K is how a public company tells investors about a major event between its quarterly reports. Companies usually have four business days to file one.
How recent is this CEO departures list?
It covers 8-K filings from the last 90 days, classified as CEO departures and sorted newest first. The Massive 8-K disclosures API has the full, continuously updated record.
Build with AI
Track these filings with your agent
This page is built from the Massive 8-K disclosures endpoint. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check the 8-K disclosures endpoint once a day for new filings classified as CEO departures (query tertiary_category=ceo_departure) and tell me about each new one, with the company, filing date, excerpt and SEC link.
Live market data from the Massive API and MCP.Get a free API key
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.